MetaADEDB 2.0 @ LMMD
Anal inflammation
(UMLS:C0238634)
UMLS ID:
C0238634
MeSH ID:
N/A
Synonym(s)
1.
Anal inflammation
2.
Inflammation of anus
3.
anal inflammation
4.
anus inflammation
5.
inflamed anus
6.
inflammation anus
7.
inflammation of anus
Associated Drug(s)
NameNumber of ReportsReference(s)Data Source
1LamotrigineFAERS: 9US FAERS
2SunitinibFAERS: 7US FAERS
3rofecoxibFAERS: 3US FAERS
4CiprofloxacinFAERS: 2US FAERS
5Imatinib MesylateFAERS: 2US FAERS
6IsotretinoinFAERS: 2US FAERS
7cabozantinibFAERS: 2SIDER
US FAERS
8regorafenibFAERS: 2US FAERS
9AzacitidineFAERS: 1US FAERS
10AzithromycinFAERS: 1US FAERS
11Cabozantinib S-malateFAERS: 1US FAERS
12CapecitabineFAERS: 1OFFSIDES
US FAERS
13ClarithromycinFAERS: 1US FAERS
14ClofarabineFAERS: 1US FAERS
15Duloxetine HydrochlorideFAERS: 1US FAERS
16Estrogens, Conjugated (USP)FAERS: 1US FAERS
17EverolimusFAERS: 1US FAERS
18Ibandronic AcidFAERS: 1US FAERS
19MDV 3100FAERS: 1US FAERS
20MemantineFAERS: 1US FAERS
21N-(4-(3-chloro-4-(2-pyridinylmethoxy)anilino)-3-cyano-7-ethoxy-6-quinolyl)-4-(dimethylamino)-2-butenamideFAERS: 1US FAERS
22NorgestrelFAERS: 1US FAERS
23Sildenafil CitrateFAERS: 1US FAERS
24SorafenibFAERS: 1OFFSIDES
US FAERS
25TopiramateFAERS: 1US FAERS
26TramadolFAERS: 1US FAERS
27ValacyclovirFAERS: 1US FAERS
28VareniclineFAERS: 1US FAERS
29apremilastFAERS: 1US FAERS
30linaclotideFAERS: 1US FAERS
31liposomal doxorubicinFAERS: 1US FAERS
32pazopanibFAERS: 1US FAERS
33temsirolimusFAERS: 1US FAERS
34AxitinibOFFSIDES
35CytarabineSIDER
36DicyclomineOFFSIDES
37IrinotecanOFFSIDES
38LapatinibOFFSIDES
39LeucovorinOFFSIDES
40PamidronateOFFSIDES
41Salmeterol XinafoateOFFSIDES
42SunitinibOFFSIDES
43Zoledronic AcidOFFSIDES
44cefuroxime axetilOFFSIDES
45chlorhexidine gluconateOFFSIDES
46tegaserodOFFSIDES
47tegaserodOFFSIDES
Powered by :

Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120241

Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.